跳至主要内容
临床试验/EUCTR2015-002667-42-NL
EUCTR2015-002667-42-NL
进行中(未招募)
不适用

Sedation with propofol TCI during ERCP: Is the combination with esketamine more effective and safer than with alfentanil (SPEKA): A randomized controlled multicentre trial - SPEKA

AMC0 个研究点2015年9月2日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Patients undergoing ERCPs under propofol sedation combined with ketamine or alfentanil given by trained anesthesia nurse.
发起方
AMC
状态
进行中(未招募)
最后更新
10年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2015年9月2日
结束日期
待定
最后更新
10年前
研究类型
Interventional clinical trial of medicinal product
性别
All

研究者

发起方
AMC

入排标准

入选标准

  • The patients must comply with the following criteria in order to be eligible to participate in this clinical study:
  • Age range \= 18 years
  • ASA classification I – III
  • Planned ERCP procedure
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 100
  • F.1\.3 Elderly (\>\=65 years) yes

排除标准

  • Patient will be excluded if the following criteria are applicable:
  • Age range \< 18 years
  • ASA classification IV and V
  • Allergic reaction to planned medication in the patients’ medical history
  • Unregulated hypertension
  • History of malignant hypertension
  • Significant ischaemic heart disease
  • Mentally disordered
  • History of psychological problems or psychiatric disease
  • Use of drugs that affect the central nervous system

结局指标

主要结局

未指定

相似试验